The first consideration is drug-induced hypoglycemia: some drugs such as sulfonylureas can stimulate the secretion of human islets, causing a decrease in blood glucose, or immunosuppressive agents can also affect normal tissues (such as islet β cells producing insulin) while exerting anti-tumor responses, resulting in changes in blood glucose. The gene discussed is INS; the disease is neoplasm.